Quince Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

IRulya Therapeutics

09/11/2024 24:42

* Quince Therapeutics Inc  QNCX.OQ   QNCX.O  is expected
to report
resultson November 12 (estimated) for the period ending
September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Quince Therapeutics Inc
is for
a loss of 10 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for Quince
Therapeutics Inc is $12.00​, above​ its last closing price
of $1.70. ​​​

This summary was machine generated November 9 at 00:42 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)